E 5 Pharma

Methapharm is a pharmaceutical company located in Coral Springs, Florida, dedicated to providing high-quality medical products and services. With a focus on business development and a robust product pipeline, Methapharm actively collaborates with partners to enhance healthcare solutions across North America and Europe. The company maintains a strong commitment to customer service and addresses medical inquiries and product complaints efficiently. Methapharm's operational footprints extend across multiple locations, including facilities in Canada and Europe, underscoring its international presence in the pharmaceutical industry. Generated from the website

Leo Pharmaceuticals Inc is a global leader in medical dermatology, dedicated to advancing the standard of care for people with skin conditions. With a rich legacy dating back to 1908 and headquartered in Denmark, they are majority owned by the LEO Foundation and have a strong focus on research and development to provide innovative treatment options. Committed to responsible and ethical business practices, Leo Pharmaceuticals aims to make a true difference in the lives of individuals living with skin diseases through strategic partnerships and alliances. Through their established portfolio and new treatment options, Leo Pharmaceuticals helps people achieve healthy skin by combining their expertise in dermatology with a commitment to compliance and sustainability. Their mission is to empower patients, ensure sustainable operations, and promote diversity and inclusion in the healthcare industry. With a vision to become a more sustainable company and deliver a financial turnaround by 2023, Leo Pharmaceuticals is dedicated to pioneering together with their team, patients, and partners to continuously improve and extend possibilities in medical dermatology.Generated from the website

ReceptoPharm Inc., a nutra pharma company, is a biopharmaceutical drug discovery company, located in Plantation, Fla. It develops proprietary therapeutic protein products primarily for the prevention and treatment of viral, and the autoimmune and neurological diseases in humans. Incorporated as Receptogen in the United States under the laws of the State of Nevada on June 4, 2001, the company gained its current name in April of 2003. ReceptoPharm Inc. offers a full range of contract products and services catering to start-up and small biotechnology companies. These include pre-production studies, contract manufacturing services, US & EU regulatory support and quality systems/GMP certification products.